HER2-Positive Breast Cancer Treatment Market Insights and Forecast to 2032
January 24, 2024 10:35 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "HER2-Positive Breast Cancer - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. ...
Global Antibody Drug Conjugates Market Poised to Reach $19.8 Billion by 2028, Fueled by Increasing Cancer Prevalence and Clinical Advancements
October 26, 2023 07:33 ET
|
Research and Markets
Dublin, Oct. 26, 2023 (GLOBE NEWSWIRE) -- The "Global Antibody Drug Conjugates (ADC) Market by Product (Kadcyla, Enhertu, Padcev, Polivy), Linker Type (Cleavable, Non-Cleavable), Payload Type...
Global Antibody Drug Conjugates Market to 2030: Rising Incidences of Cancer Worldwide Bolsters Growth
June 01, 2023 11:53 ET
|
Research and Markets
Dublin, June 01, 2023 (GLOBE NEWSWIRE) -- The "Global Antibody Drug Conjugates Market Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.The Global Antibody Drug...
Asia Pacific Antibody Drug Conjugates Market Report 2022-2027: Featuring Key Players Daiichi Sankyo, Eisai, Takeda Pharmaceutical, Pfizer & Others
August 04, 2022 04:48 ET
|
Research and Markets
Dublin, Aug. 04, 2022 (GLOBE NEWSWIRE) -- The "Asia Pacific Antibody Drug Conjugates Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering. The rapidly...
Antibody Drug Conjugates Market to Surpass US$ 11.01 Billion, Globally, by end of 2028, Says Coherent Market Insights (CMI)
November 15, 2021 08:40 ET
|
CMI
SEATTLE, Nov. 15, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global antibody drug conjugates market is estimated to be valued at US$ 4.29 billion in 2021 and is expected to...
HER2 Targeting Therapies Market Assessment 2021-2030 with Profiles of AstraZeneca, Boehringer Ingelheim, GSK, MacroGenics, Pfizer, Puma Biotechnology, Roche, Seagen, Triumvira Immunologics, Zymeworks
September 29, 2021 06:13 ET
|
Research and Markets
Dublin, Sept. 29, 2021 (GLOBE NEWSWIRE) -- The "HER2 Targeting Therapies Market by Target Disease Indication, Type of Molecule, Type of Therapy and Route of Administration, Key Geographical Regions:...
Global HER2+ Breast Cancer Market Will Expand to 12.1 Billion in 2030
September 21, 2021 05:43 ET
|
Research and Markets
Dublin, Sept. 21, 2021 (GLOBE NEWSWIRE) -- The "HER2+ Breast Cancer - Global Drug Forecast and Market Analysis to 2030" report has been added to ResearchAndMarkets.com's offering. Breast cancer is...
Cybrexa Therapeutics Announces Expansion of Its Anticancer Pipeline
December 09, 2019 08:30 ET
|
Cybrexa Therapeutics
NEW HAVEN, Conn., Dec. 09, 2019 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics, a biotechnology company developing a new class of cancer therapeutics through its alphalex™ tumor targeting platform, today...